EICHOR
● Active Not Recruiting
A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to compare the pharmacokinetics (processes by which drugs are absorbed, distributed in the body, and excreted) between teclistamab made from the current commercial manufacturing process (pre-change) and the new manufacturing process (post-change).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (53)
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | — |
| Colorado Blood Cancer Institute | Denver, Colorado, United States | — |
| Cleveland Clinic Florida | Weston, Florida, United States | — |
| Augusta University- Georgia Cancer Center | Augusta, Georgia, United States | — |
| St Francis Hospital & Health Centers Indiana Blood and Marrow Transplantation Franciscan Health | Indianapolis, Indiana, United States | — |
| Cleveland Clinic | Cleveland, Ohio, United States | — |
| Baylor University Medical Center | Dallas, Texas, United States | — |
| Flinders Medical Centre | Bedford Park, Australia | — |
| Box Hill Hospital | Box Hill, Australia | — |
| Royal Prince Alfred Hospital | Camperdown, Australia | — |
| Epworth Healthcare | Richmond, Australia | — |
| Cross Cancer Institute | Edmonton, Alberta, Canada | — |
+ 41 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06425991